Dr. Daniela Molena, MD, is an experienced thoracic surgeon specializing in the diagnosis and treatment of cancers of the chest, including cancers of the lungs, esophagus, mediastinum, and pleura. She serves as Director of the Esophageal Program at Memorial Sloan Kettering Cancer Center (MSK), where she leads a dedicated team focused on esophageal cancer care. Dr. Molena also brings deep expertise in benign esophageal diseases, including gastroesophageal reflux disease (GERD), Barrett's esophagus, hiatal hernia, and dysmotility disorders such as achalasia, diverticula, and ineffective motility. Performing approximately 500 operations and caring for roughly 1,500 patients each year, she employs minimally invasive techniques whenever possible, including video-assisted thoracic surgery and laparoscopic and robotic procedures, to reduce pain and speed recovery.
Why they are a top doctor
Research papers · PubMed
271
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
9.2k
How often other doctors and researchers build on their work.
Known for
Bronchoscopy and endobronchial ultrasound (EBUS)
The distinction that sets them apart from other thoracic surgeons.
Specializes in
Surgical endoscopy and minimally invasive surgery
A narrow focus means they see far more of these cases than a general surgeon.
Background
Education
Medical school: MD, University of Padova School of Medicine
Residency: General Surgery - University of Padova · General Surgery - University of Rochester Medical Center
Fellowship: Gastrointestinal Surgery - University of California San Francisco · Minimally Invasive Surgery - University of Padova · Cardiothoracic Surgery - NewYork Presbyerian/Weill Cornell Medical Center · Cardiothoracic Surgery - University of Pittsburgh Medical Center · Cardiothoracic Surgery - Memorial Sloan Kettering Cancer Center
Board certifications: Thoracic Surgery · General Surgery
Awards
President, Women in Thoracic Surgery (2023-2025
American Registry, Most Honored Professionals, Patients’ Choice (2017-2022)